Welcome to LookChem.com Sign In|Join Free

CAS

  • or

685827-70-7

Post Buying Request

685827-70-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

685827-70-7 Usage

General Description

N-(pyrid-2-yl)piperidine-4-carboxylic acid is a chemical compound with the molecular formula C13H16N2O2. It is classified as a carboxylic acid and contains a piperidine ring with a pyridine group attached to it. N-(PYRID-2-YL)PIPERIDINE-4-CARBOXYLIC ACID is used as a building block in organic synthesis and pharmaceutical research. It may also be used as a precursor in the synthesis of various pharmaceuticals and biologically active molecules. Its structure and properties make it a valuable intermediate in the production of diverse chemical compounds. Overall, N-(pyrid-2-yl)piperidine-4-carboxylic acid is a versatile chemical that has important applications in the pharmaceutical and chemical industries.

Check Digit Verification of cas no

The CAS Registry Mumber 685827-70-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,5,8,2 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 685827-70:
(8*6)+(7*8)+(6*5)+(5*8)+(4*2)+(3*7)+(2*7)+(1*0)=217
217 % 10 = 7
So 685827-70-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O2/c14-11(15)9-4-7-13(8-5-9)10-3-1-2-6-12-10/h1-3,6,9H,4-5,7-8H2,(H,14,15)

685827-70-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-pyridin-2-ylpiperidine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-Pyridin-2-yl-piperidine-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:685827-70-7 SDS

685827-70-7Relevant articles and documents

Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease

Lu, Tianbao,Connolly, Peter J.,Philippar, Ulrike,Sun, Weimei,Cummings, Maxwell D.,Barbay, Kent,Gys, Luc,Van Nuffel, Luc,Austin, Nigel,Bekkers, Mariette,Shen, Fang,Cai, Ann,Attar, Ricardo,Meerpoel, Lieven,Edwards, James

, (2019)

We describe a series of potent and highly selective small-molecule MALT1 inhibitors, optimized from a High-Throughput Screening hit. Advanced analogues such as compound 40 show high potency (IC50: 0.01 μM) in a biochemical assay measuring MALT1 enzymatic activity, as well as in cellular assays: Jurkat T cell activation (0.05 μM) and IL6/10 secretion (IC50: 0.10/0.06 μM) in the TMD8 B-cell lymphoma line. Compound 40 also inhibited cleavage of the MALT1 substrate RelB (IC50: 0.10 μM). Mechanistic enzymology results suggest that these compounds bind to the known allosteric site of the protease.

Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity

De Candia, Modesto,Fiorella, Filomena,Lopopolo, Gianfranco,Carotti, Andrea,Romano, Maria Rosaria,Lograno, Marcello Diego,Martel, Sophie,Carrupt, Pierre-Alain,Belviso, Benny D.,Caliandro, Rocco,Altomare, Cosimo

, p. 8696 - 8711 (2013/12/04)

The design and synthesis of a new class of nonpeptide direct thrombin inhibitors, built on the structure of 1-(pyridin-4-yl)piperidine-4-carboxamide, are described. Starting from a strongly basic 1-amidinopiperidine derivative (6) showing poor thrombin (fIIa) and factor Xa (fXa) inhibition activities, anti-fIIa activity and artificial membrane permeability were considerably improved by optimizing the basic P1 and the X-substituted phenyl P4 binding moieties. Structure-activity relationship studies, usefully complemented with molecular modeling results, led us to identify compound 13b, which showed excellent fIIa inhibition (Ki = 6 nM), weak anti-Xa activity (K i = 5.64 μM), and remarkable selectivity over other serine proteases (e.g., trypsin). Compound 13b showed in vitro anticoagulant activity in the low micromolar range and significant membrane permeability. In mice (ex vivo), 13b demonstrated anticoagulant effects at 2 h after oral dosing (100 mg·kg-1), with a significant 43% prolongation of the activated partial thromboplastin time (aPTT), over controls (P 0.05).

1, 4-DISUBSTITUTED PIPERIDINES AS VASOPRESSIN RECEPTOR VIA ANTAGONISTS

-

Page/Page column 44, (2010/09/17)

The present invention provides compounds of formula (1) compositions comprising such compounds; the use of such compounds in therapy (such as in the treatment of dysmenorrhoea); and methods of treating patients with such compounds; wherein A and G are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 685827-70-7